1. Date of Change: April 15, 2026 2. Personnel Type (Please enter 'Corporate Director', 'Corporate Supervisor', 'Independent Director', 'Individual Director', or 'Individual Supervisor'): Independent Director 3. Former Title and Name: Shi Bo-yuan 4. Brief Biography of Former Incumbent: Shi Bo-yuan: Head of Strategic Investment Department, Da Jiang Biological Technology Co., Ltd. 5. New Title and Name: Not applicable 6. Brief Biography of New Appointee: Not applicable 7. Reason for Change (Please enter 'Resignation', 'Dismissal', 'Term Expiration', 'Death', or 'New Appointment'): Resignation 8. Reason for Change: Statement from the committee: Due to the dismissal ruling made by the commercial court in case number 115 Commercial Interim No. 3, the committee believes it is no longer possible to effectively exercise the supervisory responsibilities of an independent director and audit committee member to safeguard the best interests of the company and all shareholders. Therefore, it has been decided to resign from the position of independent director of the company, effective April 15, 2026, simultaneously resigning from the positions of audit committee member and compensation committee member. This statement is made on this date. 9. Number of Shares Held by New Appointee at Time of Election: Not applicable 10. Original Term (e.g., xx/xx/xx ~ xx/xx/xx): November 22, 2024 ~ November 21, 2027 11. Effective Date of New Appointment: Not applicable 12. Change Ratio of Directors in the Same Term: 1/9 13. Change Ratio of Independent Directors in the Same Term: 1/3 14. Change Ratio of Supervisors in the Same Term: Not applicable 15. Whether more than one-third of directors have changed (Please enter Yes or No): No 16. Other Matters to be Noted (If the subject of the event or resolution is a publicly issued or higher company, this major information also meets the criteria for matters significantly affecting shareholder rights or securities prices as stipulated in Article 7, Paragraph 6 of the Enforcement Rules of the Securities Transaction Act): None.
FACT BOX
- Source: PR Times
- Category: 人事